This inventor holds 1 USPTO granted patent. Top assignee: Boehringer Mannheim Gmbh. Active years: 1992.
Company Filing History:
Years Active: 1992
Title: The Innovations of Erko Stackenbrandt
Introduction
Erko Stackenbrandt is a notable inventor based in Danischenhagen, Germany. He has made significant contributions to the field of molecular biology, particularly in the detection of pathogenic bacteria. His work has implications for public health and medical diagnostics.
Latest Patents
Erko Stackenbrandt holds a patent for the "Detection of Neisseria gonorrhoeae." This patent involves an oligonucleotide probe that is specific for Neisseria gonorrhoeae, selected from the oligonucleotides RS2* and RS3*, RS2**, and RS3**. The probe can include additional nucleotides at its 5' and/or 3' ends. It is designed for the specific detection of nucleic acids from the pathogenic species N. gonorrhoeae through hybrid formation under hybridization conditions. This innovation is crucial for accurate diagnosis and treatment of gonorrhea.
Career Highlights
Erko Stackenbrandt is associated with Boehringer Mannheim GmbH, a company known for its advancements in biotechnology and diagnostics. His work at the company has allowed him to focus on developing innovative solutions for detecting infectious diseases.
Collaborations
Some of his notable coworkers include Karin Wolff and Anne Stern. Their collaboration has likely contributed to the success of the projects they have worked on together.
Conclusion
Erko Stackenbrandt's contributions to the field of molecular diagnostics, particularly through his patent for detecting Neisseria gonorrhoeae, highlight his role as an influential inventor. His work continues to impact public health positively.